BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32665996)

  • 1. Preintervention risk stratification of renal pelvic cancer and ureteral cancer should differ.
    Yang T; Zhang N; Yang B; He D; Fan J; Fan J
    Investig Clin Urol; 2020 Jul; 61(4):397-404. PubMed ID: 32665996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria.
    Zhang X; Zhu Z; Zhong S; Xu T; Shen Z
    World J Urol; 2013 Feb; 31(1):155-60. PubMed ID: 22614444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
    Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
    Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 123 cases of transitional cell carcinoma (TCC) of upper urinary tract].
    Liang YY; Dai YP; Huang ZY; Zheng KL; Mei H
    Ai Zheng; 2005 Jan; 24(1):91-4. PubMed ID: 15642209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study of renal pelvic and ureteral cancer: prognosis and frequency of subsequent bladder cancer following surgical treatment].
    Watanabe M; Hayashi T; Takamatsu M; Kamitani A; Inoue M; Morisue K; Irie S; Kaneshige T
    Nihon Hinyokika Gakkai Zasshi; 2003 Mar; 94(3):428-33. PubMed ID: 12710077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
    Gandaglia G; Bianchi M; Trinh QD; Becker A; Larouche A; Abdollah F; Roghmann F; Tian Z; Shariat SF; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
    Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes.
    Yap SA; Schupp CW; Chamie K; Evans CP; Koppie TM
    Urology; 2011 Jul; 78(1):87-92. PubMed ID: 21601253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma.
    Stein B; Schrader AJ; Wegener G; Seidel C; Kuczyk MA; Steffens S
    BMC Cancer; 2013 Mar; 13():101. PubMed ID: 23497335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urothelial tumors of the upper urinary tract].
    Lancina Martín JA; Gómez Veiga F; García Buitrón JM; González Martín M
    Actas Urol Esp; 1985; 9(5):403-8. PubMed ID: 3832818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.